Antimicrobial stewardship for outpatients with chronic bone and joint infections in the orthopaedic clinic of an academic tertiary hospital, South Africa
Masetla, Mankoana A. and Ntuli, Pinky N. and Abraham, Veena and Godman, Brian and Witika, Bwalya A. and Mudenda, Steward and Skosana, Phumzile P. (2023) Antimicrobial stewardship for outpatients with chronic bone and joint infections in the orthopaedic clinic of an academic tertiary hospital, South Africa. Antibiotics, 12 (7). 1142. ISSN 2079-6382 (https://doi.org/10.3390/antibiotics12071142)
Preview |
Text.
Filename: Masetla_etal_antibiotics_2023_Antimicrobial_stewardship_for_outpatients_with_chronic_bone_and_joint_infections.pdf
Final Published Version License: Download (538kB)| Preview |
Abstract
Bone and joint infections are associated with prolonged hospitalizations, high morbidity and complexity of care. They are difficult to treat, and successful therapy requires organism-specific antimicrobial therapy at high doses for a prolonged duration as recommended in standard treatment guidelines (STGs). Adherence to the treatment plan is equally important, which is enhanced with knowledge of the condition as well as appropriate antibiotics. Consequently, the aim of this study was to provide antimicrobial stewardship (AMS) services to outpatients with chronic bone and joint infections presenting to the orthopaedic clinic at a public South African tertiary hospital. A total of 44 patients participated in this study. Chronic osteomyelitis was diagnosed in 39 (89%) patients and septic arthritis in 5 (11%). The majority (43%) of infections were caused by Staphylococcus aureus followed by Pseudomonas aeruginosa (14%). Seventy-one antibiotics were prescribed at baseline with rifampicin prescribed the most (39%), followed by ciprofloxacin (23%). The majority (96%) of the antibiotics were not prescribed according to the South African STG; however, interventions were only needed in 31% of prescribed antibiotics (n = 71) since the STG only recommends empiric therapy directed against Staphylococcus aureus. Seventy-seven percent of the patients obtained a high self-reported adherence score at baseline. Consequently, there is a need to improve AMS in bone and joint infections to improve future care.
-
-
Item type: Article ID code: 86032 Dates: DateEvent1 July 2023Published29 June 2023Accepted11 May 2023SubmittedSubjects: Medicine > Pharmacy and materia medica Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 04 Jul 2023 14:49 Last modified: 11 Nov 2024 13:59 URI: https://strathprints.strath.ac.uk/id/eprint/86032